Connection

Patrick O'Neil to Adult

Back to Details
This is a "connection" page, showing publications Patrick O'Neil has written about Adult.
Patrick O'Neil
Connection Strength
0.777
Adult
  1. Pilot evaluation of a personalized commercial program on weight loss, health outcomes, and quality of life. Transl Behav Med. 2021 12 14; 11(12):2091-2098.
    View in: PubMed
    Score: 0.056
  2. Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
    View in: PubMed
    Score: 0.049
  3. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. Lancet. 2018 08 25; 392(10148):637-649.
    View in: PubMed
    Score: 0.044
  4. Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials. Diabetes Obes Metab. 2017 11; 19(11):1529-1536.
    View in: PubMed
    Score: 0.041
  5. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
    View in: PubMed
    Score: 0.040
  6. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
    View in: PubMed
    Score: 0.039
  7. Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016 09; 6(3):339-46.
    View in: PubMed
    Score: 0.039
  8. EFFECTS OF LIRAGLUTIDE 3.0 MG ON WEIGHT AND RISK FACTORS IN HISPANIC VERSUS NON-HIPANIC POPULATIONS: SUBGROUP ANALYSIS FROM SCALE RANDOMIZED TRIALS. Endocr Pract. 2016 11; 22(11):1277-1287.
    View in: PubMed
    Score: 0.039
  9. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
    View in: PubMed
    Score: 0.032
  10. Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
    View in: PubMed
    Score: 0.032
  11. Changes in weight control behaviors and hedonic hunger during a 12-week commercial weight loss program. Eat Behav. 2012 Dec; 13(4):354-60.
    View in: PubMed
    Score: 0.029
  12. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012 Jul; 20(7):1426-36.
    View in: PubMed
    Score: 0.028
  13. Socially desirable responding by bariatric surgery candidates during psychological assessment. Surg Obes Relat Dis. 2013 Mar-Apr; 9(2):300-5.
    View in: PubMed
    Score: 0.027
  14. Blood naltrexone and 6-beta-naltrexol levels following naltrexone implant: comparing two naltrexone implants. Addict Biol. 2004 Mar; 9(1):59-65.
    View in: PubMed
    Score: 0.016
  15. Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trial. Obes Res. 2002 Jul; 10(7):633-41.
    View in: PubMed
    Score: 0.015
  16. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021 04 13; 325(14):1403-1413.
    View in: PubMed
    Score: 0.013
  17. Which comes first in the pathogenesis of bulimia nervosa: dieting or bingeing? Int J Eat Disord. 2000 Nov; 28(3):259-64.
    View in: PubMed
    Score: 0.013
  18. The perceived relative worth of reaching and maintaining goal weight. Int J Obes Relat Metab Disord. 2000 Aug; 24(8):1069-76.
    View in: PubMed
    Score: 0.013
  19. Description, utilisation and results from a telehealth primary care weight management intervention for adults with obesity in South Carolina. J Telemed Telecare. 2020 Jan-Feb; 26(1-2):28-35.
    View in: PubMed
    Score: 0.011
  20. The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
    View in: PubMed
    Score: 0.011
  21. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care. 2018 08; 41(8):1590-1599.
    View in: PubMed
    Score: 0.011
  22. The National Women's Study: relationship of victimization and posttraumatic stress disorder to bulimia nervosa. Int J Eat Disord. 1997 Apr; 21(3):213-28.
    View in: PubMed
    Score: 0.010
  23. Effects of body fat distribution on body size estimation accuracy among obese women. Int J Obes Relat Metab Disord. 1997 Mar; 21(3):250-3.
    View in: PubMed
    Score: 0.010
  24. Early Weight Loss with Liraglutide 3.0 mg Predicts 1-Year Weight Loss and is Associated with Improvements in Clinical Markers. Obesity (Silver Spring). 2016 11; 24(11):2278-2288.
    View in: PubMed
    Score: 0.010
  25. The relationship between early weight loss and weight loss at 1 year with naltrexone ER/bupropion ER combination therapy. Int J Obes (Lond). 2016 09; 40(9):1369-75.
    View in: PubMed
    Score: 0.010
  26. The number of divergent purging behaviors is associated with histories of trauma, PTSD, and comorbidity in a national sample of women. Eat Disord. 2015; 23(5):422-9.
    View in: PubMed
    Score: 0.009
  27. Early weight loss while on lorcaserin, diet and exercise as a predictor of week 52 weight-loss outcomes. Obesity (Silver Spring). 2014 Oct; 22(10):2137-46.
    View in: PubMed
    Score: 0.008
  28. A comparison of women with child-adolescent versus adult onset binge eating: results from the National Women's Study. Int J Eat Disord. 2014 Nov; 47(7):836-43.
    View in: PubMed
    Score: 0.008
  29. Executive control circuitry differentiates degree of success in weight loss following gastric-bypass surgery. Obesity (Silver Spring). 2013 Nov; 21(11):2189-2196.
    View in: PubMed
    Score: 0.008
  30. The Food Craving Questionnaire-Trait in a bariatric surgery seeking population and ability to predict post-surgery weight loss at six months. Eat Behav. 2012 Dec; 13(4):366-70.
    View in: PubMed
    Score: 0.007
  31. Prefrontal cortex transcranial direct current stimulation (tDCS) temporarily reduces food cravings and increases the self-reported ability to resist food in adults with frequent food craving. Appetite. 2011 Jun; 56(3):741-6.
    View in: PubMed
    Score: 0.007
  32. Seasonal patterns of birth for subjects with bulimia nervosa, binge eating, and purging: results from the National Women's Study. Int J Eat Disord. 2012 Jan; 45(1):131-4.
    View in: PubMed
    Score: 0.007
  33. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity (Silver Spring). 2011 Jan; 19(1):110-20.
    View in: PubMed
    Score: 0.006
  34. Rational design of a combination medication for the treatment of obesity. Obesity (Silver Spring). 2009 Jan; 17(1):30-9.
    View in: PubMed
    Score: 0.006
  35. The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite. 2008 Sep; 51(2):324-6.
    View in: PubMed
    Score: 0.005
  36. Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss. Obesity (Silver Spring). 2007 Apr; 15(4):895-905.
    View in: PubMed
    Score: 0.005
  37. A comparison of mental health hospital admissions in a cohort of heroin users prior to and after rapid opiate detoxification and oral naltrexone maintenance. Am J Drug Alcohol Abuse. 2007; 33(5):655-64.
    View in: PubMed
    Score: 0.005
  38. Vagus nerve stimulation acutely alters food craving in adults with depression. Appetite. 2007 Mar; 48(2):145-53.
    View in: PubMed
    Score: 0.005
  39. Changes in food cravings during low-calorie and very-low-calorie diets. Obesity (Silver Spring). 2006 Jan; 14(1):115-21.
    View in: PubMed
    Score: 0.005
  40. Findings and outcomes of psychological evaluations of gastric bypass applicants. Surg Obes Relat Dis. 2005 Nov-Dec; 1(6):523-7; discussion 528-9.
    View in: PubMed
    Score: 0.005
  41. Smoking status and weight loss in three weight loss programs. Eat Behav. 2006 Jan; 7(1):61-8.
    View in: PubMed
    Score: 0.004
  42. Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003 Aug; 27(8):970-8.
    View in: PubMed
    Score: 0.004
  43. Restraint and age at onset of obesity. Addict Behav. 1981; 6(2):135-8.
    View in: PubMed
    Score: 0.003
  44. A prospective study of holiday weight gain. N Engl J Med. 2000 Mar 23; 342(12):861-7.
    View in: PubMed
    Score: 0.003
  45. Psychosocial aspects of total parenteral nutrition. Psychosomatics. 1980 Feb; 21(2):115-25.
    View in: PubMed
    Score: 0.003
  46. Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study. Am J Clin Nutr. 1999 Jun; 69(6):1108-16.
    View in: PubMed
    Score: 0.003
  47. Cognitive appraisals of dietary transgressions by obese women: associations with self-reported eating behavior, depression, and actual weight loss. Int J Obes Relat Metab Disord. 1999 Mar; 23(3):231-7.
    View in: PubMed
    Score: 0.003
  48. Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: a retrospective investigation. Addict Behav. 1979; 4(2):167-77.
    View in: PubMed
    Score: 0.003
  49. Cycles of dose-intensive chemotherapy with peripheral stem cell support in persistent or recurrent platinum-sensitive ovarian cancer. Gynecol Oncol. 1997 Dec; 67(3):272-6.
    View in: PubMed
    Score: 0.003
  50. Prevalence of binge eating disorder in obese adults seeking weight loss treatment. Eat Weight Disord. 1997 Sep; 2(3):117-24.
    View in: PubMed
    Score: 0.003
  51. Comorbidity of axis I psychiatric disorders in bulimia nervosa. J Clin Psychiatry. 1995 Feb; 56(2):77-80.
    View in: PubMed
    Score: 0.002
  52. Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder. Psychopharmacol Bull. 1993; 29(2):183-8.
    View in: PubMed
    Score: 0.002
  53. CSF monoamine levels in normal-weight bulimia: evidence for abnormal noradrenergic activity. Am J Psychiatry. 1990 Feb; 147(2):225-9.
    View in: PubMed
    Score: 0.002
  54. Depression and bulimia: the link between depression and bulimic cognitions. J Abnorm Psychol. 1989 Aug; 98(3):322-5.
    View in: PubMed
    Score: 0.001
  55. Precursor amino acid concentrations in normal weight bulimics and normal controls. Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12(6):893-8.
    View in: PubMed
    Score: 0.001
  56. Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry. 1987 Jun; 22(6):710-6.
    View in: PubMed
    Score: 0.001
  57. A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
    View in: PubMed
    Score: 0.001
  58. Experienced control and participation in treatment of obesity. Psychol Rep. 1980 Dec; 47(3 Pt 2):1127-34.
    View in: PubMed
    Score: 0.001
  59. Taste hedonics and thresholds in obesity. Int J Obes. 1980; 4(3):203-12.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.